期刊文献+

LC-MS/MS法测定人血浆中米格列醇

LC-MS/MS determination of miglitol in human plasma
下载PDF
导出
摘要 目的:建立测定人血浆中米格列醇的 LC-MS/MS 法。方法:以盐酸格拉司琼为内标,以 Kromasil CN 柱(2.1 mm×150mm,3.0μm)为分析柱;采用0.05%三氟乙酸乙腈溶液-0.05%三氟乙酸水溶液(80:20)为流动相;流速0.2 mL·min^(-1);柱温45℃。质谱条件为电喷雾电离源(ESI^+),以选择反应离子监测(SRM)方式进行检测,用于定量分析的反应离子分别为 m/z208.1→146.1(米格列醇),m/z 313.1→138.0(盐酸格拉司琼)。结果:米格列醇在0.01~4.0μg·mL^(-1)浓度范围内线性良好;最低检测限为2.0 ng·mL^(-1)(S/N=4);日内、日间精密度(RSD)均小于7%;低、中、高3个浓度的方法回收率均大于90%。结论:本法专属性强,灵敏度高,样品处理简单,可用于米格列醇临床药物动力学研究。 Objective: To establish an LC - MS/MS method for the determination of miglitol in the human plasma. Methods:Granisetron hydrochloride was used as the internal standard. The separation and analysis was performed on a Kromasil CN column(2.1mm×150mm,3.0μm). The mobile phase consisted of 0. 05% trifluoroacetic acid acetonitrile solution-0.05% trifluoroacetic acid aqueous solution(80: 20). The flow rate was 0. 2 mL · min^-1 and column temperature was 45℃. Electrospray ionization (ESI) source was applied and operated in the positive mode. Selected reaction monitoring(SRM) mode with the transitions of m/z 208. 1→146. 1 and m/z 313. 1→138.0 were adopted to quantify miglitol and granisetron hydrochloride ( internal standard), respectively. Results: The assay linearities of miglitol was confirmed over the range of 0.01 -4. 0 μg·mL^-1, and the detection limit was 2. 0 ng·mL^-1. The intra and inter - day precision (RSD) were less than 7 %. The average recoveries were above 90%. Conclusion :The method is proved to be specific, sensitive and covenient for the clinical pharmacokinetic studies of miglitol.
出处 《药物分析杂志》 CAS CSCD 北大核心 2007年第8期1193-1196,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 米格列醇 液相色谱串联质谱 血浆药物浓度 miglitol LC - MS/MS plasma concentration
  • 相关文献

参考文献3

二级参考文献7

  • 1Segal P, Feig PU, Schemthaner G, et al.The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone[ J ]. Diabetes Care, 1997,20,5:687.
  • 2Johnson AB, Taylor R. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type Ⅱ diabetic patients[J]. Diabetes Care, 1996,19(6) :559.
  • 3Walsh PM. Physician' s desk reference[M].56th edition. Montral,NJ:Thomson PDR,2002.2821 - 2823.
  • 4Scott LJ, Spencer CM. Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus [J]. Drugs, 2000, 59(3):521~549.
  • 5Ahr H-J, Boberg M, Brendel E, et al. Pharmacokinetics of miglitol: absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man [J]. Arzneimittelforschung,1997,47: 734~745.
  • 6Beneke PC,M(u)ller FO, Van Dyk M, et al. The pharmacokinetics of miglitol over a therapeutic dose range [J]. S Afr Med J, 1991,(7)80: 622.
  • 7何素婷,许激扬,陈代杰.具有α-葡糖苷酶抑制作用的抗糖尿病药物[J].工业微生物,2003,33(1):42-49. 被引量:37

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部